Trial Profile
Multicenter prospective randomized controlled clinical study of Apatinib combined with FLOT perioperative Chemotherapy and surgery for treatment of III stage Advanced Gastric Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2020
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Docetaxel; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2020 Status changed from not yet recruiting to recruiting.
- 21 Sep 2020 Results (n=64) presented at the 45th European Society for Medical Oncology Congress.
- 12 Oct 2017 New trial record